Skip navigation

You are here: CIDR>About CIDR> General




The Center for Inherited Disease Research's mission is to support the genetics community by providing high quality, cutting-edge genomic services and technologies in order to expand our understanding of disease and catalyze discoveries that translate to patient care.


CIDR is a valuable national resource for cutting-edge genetic research. CIDR was established at the Johns Hopkins University in 1996. CIDR provides high quality next generation sequencing and genotyping services to investigators working to discover genes that contribute to disease. On-site statistical geneticists provide valuable insight into analysis issues as they relate to study design, data production and quality control. Completed studies encompass over 200 phenotypes across 900 projects and over 1.2 million samples from over 300 different principal investigators located world-wide. The impact is evidenced by over 1,190 peer-review publications.


In response to the expanding field of genetics, CIDR rapidly implements new technologies and offers new production scale services while maintaining strict quality standards.



Support and Access

The CIDR facility is supported by several sources. The largest source of support is the NIH CIDR Program, a federal contract from the National Institutes of Health to the Johns Hopkins University funded by ten NIH institutes: NHGRI, NCI, NEI, NIA, NIAAA, NICHD, NIDCR, NIEHS, NINDS and the NIH Office of the Director. The CIDR contract was initially awarded in 1996, renewed in 2007 and 2012 with some overlap of funding, and competitively renewed for seven years in 2017. The federal contract numbers are:


N01-HG-65403 (1996-2008)



HHSN268200782096C (2007-2012), and HHSN268201100011I (2011-2012)



HHSN268201200008I (2012-2017)



HHSN268201700006I (2017-2023)

Funding ceiling $213,478,000


Dr. Kim Doheny, Lead Co-Principal Investigator

Dr. David Valle, Co-Principal Investigator

Dr. Alan Scott, Co-Principal Investigator

Dr. Elizabeth Pugh, Co-Investigator

Dr. Hua Ling, Co-Investigator

Dr. Christopher Gocke, Co-Investigator


The most recent contract for the NIH CIDR Program, High Throughput Genotyping and DNA Sequencing for Studying the Genetic Contributions to Human Health and Disease, was awarded January 1, 2017 and is funded by individual Task Orders. Dr. Lawrence Brody of the National Human Genome Research Institute (NHGRI) is the Government Scientific Officer.


Additional Funding

CIDR, as part of Johns Hopkins Genomics, is curently a Genome Center for the All of Us Research Program (1OT2OD002751-01, Baylor-Hopkins Clinical Genome Center) as well as a Center for Mendelian Genomics (U54HG006542, Baylor-Johns Hopkins Center for Mendelian Genetics). CIDR has previously received funding as part of multiple NHGRI-led Genome-Wide Association Study Consortia (U01HG004438, GENEVA, eMERGE, GARNET) and was a Resequencing and Genotyping (RS&G) Program Laboratory Center for NHLBI (HHSN268200448195C).


News Articles regarding the CIDR Program Renewal:


Johns Hopkins Center for Inherited Disease Research Receives $213 Million of New Funding


CIDR is a member of the Centers for Mendelian Genomics (U54HG006542, Baylor-Johns Hopkins Center for Mendelian Genetics). CIDR has been previously involved in grant awards such as multiple NHGRI-led Genome-Wide Association Study Consortia (U01HG004438, GENEVA, eMERGE, GARNET).

CIDR contracts and grants support the costs of sequencing and genotyping studies through an application, review and approval process. 

CIDR also provides sequencing and genotyping to both Johns Hopkins and outside investigators as a direct fee-for-service, requiring no application or approval process.

For more information on options for access to CIDR services please see our Access page. 




Contact Us  |  Privacy Policy  |  Site Map  |  Get Adobe Reader




photo of building


1812 Ashland at Johns Hopkins Medical Campus